Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.18 USD | -1.24% | +6.55% | -3.51% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.51% | 1.79B | |
+31.24% | 662B | |
+21.96% | 546B | |
-5.32% | 359B | |
+16.96% | 323B | |
+4.75% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.86% | 167B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences : Goldman Sachs Upgrades Harmony Biosciences Holdings to Buy From Neutral, Adjusts Price Target to $43 From $41